10/08/2014 - 10:59am

Boehringer Ingelheim on Wednesday announced that its Striverdi Respimat (olodaterol) inhalation spray in 5-mcg dosage strength is now available by prescription in pharmacies across the United States. 

10/07/2014 - 11:52am

Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.

10/07/2014 - 9:47am

Sandoz announced the launch of its dexmedetomidine hydrochloride injection, a generic version of Precedex from Hospira. 

10/07/2014 - 9:04am

Omron Healthcare on Tuesday introduced a new line of monitors that provide even more accurate results, according to the company. 

10/06/2014 - 11:43am

Mylan announced the launch of its lamivudine and zidovudine tablets USP, in 150-mg dosage strength.

10/06/2014 - 10:09am

UrgentRx on Monday announced the expansion of its product line to include UrgentRx Fast Powders 10-count multipack boxes of its single-dose packets for a variety of common ailments. 

10/01/2014 - 11:01am

Ranbaxy Labs on Wednesday announced the launch of Absorica (isotretinoin) 25 mg and 35 mg capsules into the U.S. healthcare market. 

09/30/2014 - 1:47pm

Par Pharmaceutical on Tuesday announced that it has started shipping amlodipine and valsartan tablets in all four dosage strengths.

09/30/2014 - 12:55pm

Salix Pharmaceuticals and Progenics Pharmaceuticals announced that the Food and Drug Administration approved Relistor (methylnaltrexone bromide) subcutaneous injection in 12-mg dosage strength to treat constipation in patients taking opioids for chronic, non-cancer pain.